Schneyer Mark C. sold ACAD
September 15, 2025 · Form 4 insider transaction
Schneyer Mark C. sold 3,498 shares of ACADIA Pharmaceuticals Inc. at $23.65 per share, a transaction worth $82.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
3,498
Price
$23.65
Total value
$82.7K
InsiderSchneyer Mark C.
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 15, 2025
Filing dateSeptember 16, 2025
Shares owned after43,447
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of performance stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c).